Rockwell Medical

RMTI NASDAQ
2.540
+0.160
+6.72%
交易中 14:51 08/19 EDT
开盘
2.410
昨收
2.380
最高
2.550
最低
2.360
成交量
20.70万
成交均量(3M)
46.82万
52周最高
6.88
52周最低
2.190
换手率
0.32%
市值
1.62亿
分时
5日
1月
3月
1年
5年

相关股票

微牛行情栏目提供Rockwell Medical RMTI股票价格,Rockwell Medical股票实时行情,公司简介,财报信息,股本结构等,掌握美港股行情走势,开盘价,收盘价,总市值,换手率,市盈率,收益率等数据,及时把握美股港股投资机会。

公司介绍

Rockwell Medical, Inc. (Rockwell) is a biopharmaceutical company targeting end-stage renal disease (ESRD) and chronic kidney disease (CKD) with products and services for the treatment of iron deficiency, secondary hyperparathyroidism and hemodialysis. The Company operates through the hemodialysis market segment, which involves the manufacture, sale and distribution of hemodialysis products to hemodialysis clinics, including pharmaceutical, dialysis concentrates, dialysis kits and other ancillary products used in the dialysis process. The Company's drug products include Triferic (ferric pyrophosphate citrate) and Calcitriol (Active Vitamin D) Injection. Triferic is an iron compound that is delivered to hemodialysis patients through dialysate, replacing the iron loss that occurs during their dialysis treatment. Calcitriol (active vitamin D) injection is indicated for treatment of secondary hyperparathyroidism in dialysis patients.
展开 >

最近浏览

名称
价格
涨跌幅